Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00869336 · ClinicalTrials.gov registry record · Phase 2
Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot)
A Phase 2 study, sponsored by Tinea Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 147
- Enrollment target
NCT00869336 is a Phase 2 study that has completed, run by Tinea Pharmaceuticals. The registered enrollment target is 147 participants.
The verdict
NCT00869336, a Phase 2 study, has completed, sponsored by Tinea Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 147 participants
- Enrollment target
Study Summary
To examine the safety and optimal duration of Luliconazole Cream 1% treatments for 14 days or 28 days to achieve "complete clearance" at 2 weeks post treatment.
Interventions
- DRUG Luliconazole Cream 1% - 2 wks
- DRUG Placebo Comparator -2 wks
- DRUG Luliconazole Cream 1% - 4 wks
- DRUG Placebo Comparator - 4 wks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00869336
The ClinicalTrials.gov registry entry for NCT00869336 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tinea Pharmaceuticals, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Luliconazole Cream 1% - 2 wks is the first listed.
NCT00869336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00869336 about?
NCT00869336 is a clinical study titled "Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot)". To examine the safety and optimal duration of Luliconazole Cream 1% treatments for 14 days or 28 days to achieve "complete clearance" at 2 weeks post treatment.
What is the current status of trial NCT00869336?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 147 participants. The study started on 2009-03. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00869336?
The interventions under investigation include: Luliconazole Cream 1% - 2 wks (DRUG), Placebo Comparator -2 wks (DRUG), Luliconazole Cream 1% - 4 wks (DRUG), Placebo Comparator - 4 wks (DRUG).
Who is sponsoring clinical trial NCT00869336?
This trial is sponsored by Tinea Pharmaceuticals, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.